Index of Severity for Eosinophilic Esophagitis (I-SEE)

Loading...

References

  1. Craig C Reed. Worsening Disease Severity as Measured by I-SEE Associates With Decreased Treatment Response to Topical Steroids in Eosinophilic Esophagitis Patients.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2025
  2. Corey J Ketchem. The Index of Severity for Eosinophilic Esophagitis Helps Predict Treatment Response to Dupilumab.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2025
  3. Hiroki Sato. Clinical and molecular correlates of the Index of Severity for Eosinophilic Esophagitis.. The Journal of allergy and clinical immunology, 2024
  4. C. Cotton. A newly proposed severity index for eosinophilic esophagitis is associated with baseline clinical features and successful treatment response.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2023
  5. Andrew B. Dickerson. The Index of Severity for Eosinophilic Esophagitis (I-SEE) Reflects Longitudinal Clinicopathologic Changes in Children.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2023
  6. E. Dellon. A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions.. Gastroenterology, 2022
  7. Ikuo Hirano. AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis.. Gastroenterology, 2020
  8. Matthew A Rank. Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters.. Gastroenterology, 2020
  9. Reference - 10.1056/NEJMoa2205982